???global.info.a_carregar???
Carlos Alves. Completed the Mestrado integrado in Ciências Farmacêuticas in 2009 by Universidade de Coimbra Faculdade de Farmácia, Doutoramento in Doutoramento em Ciências Farmacêuticas in 2015/02/12 by Universidade de Coimbra Faculdade de Farmácia, Doutoramento in Ciências Farmacêuticas in 2015/02 by Universidade de Coimbra Faculdade de Farmácia and Mestrado in Mestrado Integrado em Ciências Farmacêuticas in 2009 by Universidade de Coimbra. Is Assistant Professor in Universidade de Coimbra Faculdade de Farmácia. Published 42 articles in journals. Has 1 book(s). Participated in 7 event(s). Supervised 1 PhD thesis(es). Supervised 1 MSc dissertation(s). Has received 3 awards and/or honors. Works in the area(s) of Medical and Health Sciences with emphasis on Health Sciences with emphasis on Epidemiology. In his curriculum Ciência Vitae the most frequent terms in the context of scientific, technological and artistic-cultural output are: Meta-análise; Revisão sistemática; assessment; methodologidal aspects; .
Read full resume ↓
Identification

Personal identification

Full name
Carlos Alves

Citation names

  • Alves, Carlos

Author identifiers

Ciência ID
E41B-BAE4-C960
ORCID iD
0000-0003-2814-3049

Email addresses

  • carlosmiguel.costaalves@gmail.com (Professional)

Knowledge fields

  • Medical and Health Sciences - Health Sciences - Epidemiology

Languages

Language Speaking Reading Writing Listening Peer-review
English Advanced (C1) Advanced (C1) Advanced (C1) Advanced (C1)
Spanish; Castilian Intermediate (B1) Beginner (A1) Beginner (A1) Beginner (A1)
Portuguese (Mother tongue)
Education
Degree Classification
2010 - 2015/02
Concluded
 Ciências Farmacêuticas (Doutoramento)
Major in Farmácia Clínica
Universidade de Coimbra Faculdade de Farmácia, Portugal
"The role of Meta-analysis in Pharmacovigilance: how best to combine different sources of evidence about harms?" (THESIS/DISSERTATION)
2004 - 2009
Concluded
 Ciências Farmacêuticas (Mestrado integrado)
Major in Não Aplicável
Universidade de Coimbra Faculdade de Farmácia, Portugal
Affiliation

Teaching in Higher Education

Category
Host institution 		Employer
2019/09/01 - Current Assistant Professor (University Teacher) Universidade de Coimbra Faculdade de Farmácia, Portugal
2015/09/01 - 2019/08/31 Invited Assistant Professor (University Teacher) Universidade de Coimbra Faculdade de Farmácia, Portugal
2014/09/01 - 2015/08/31 Invited Assistant (University Teacher) Universidade de Coimbra Faculdade de Farmácia, Portugal

Positions / Appointments

Category
Host institution 		Employer
2024/01 - Current Co-coordenador do Mestrado em Avaliação de Tecnologias em Saúde e Acesso de Medicamentos ao Mercado (MATSAMM) Universidade de Coimbra Faculdade de Farmácia, Portugal
2021/09 - Current Coordenador do Curso de Especialização em Gestão e Direção em Saúde (GEDIS) Universidade de Coimbra Faculdade de Farmácia, Portugal

Others

Category
Host institution 		Employer
2015 - 2021 Investigador Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
2009 - 2015 Assistente de Investigação Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
Projects

Contract

Designation Funders
2010/08/01 - 2014/07/31 THE ROLE OF META-ANALYSIS IN PHARMACOVIGILANCE: HOW BEST TO COMBINE DIFFERENT SOURCES OF EVIDENCE ABOUT HARMS
SFRH/BD/64957/2009
PhD Student Fellow
Universidade de Coimbra, Portugal
 Fundação para a Ciência e a Tecnologia
Concluded
Outputs

Publications

Book
  1. Cunha-Vaz, J.; Marques, F.B.; Fernandes, R.; Alves, C.; Velpandian, T.. Drug transport across blood-ocular barriers and pharmacokinetics. 2016.
Conference poster
  1. Ribeiro, Catarina; Penedones, Ana; Mendes, Diogo; Alves, Carlos. "HTA338 Characterization of the Evidence Supporting the Relative Effectiveness Evaluations in Health Technologies Assessment: A Review". Paper presented in ISPOR Europe 2023, 2023.
  2. Ribeiro, Catarina; Penedones, Ana; Mendes, Diogo; Alves, Carlos. "HTA46 Relationship Between the Directness of the Evidence and Identification of Added Therapeutic Value: An Analysis of HTA Procedures"". Paper presented in ISPOR Europe 2023, 2023.
  3. Penedones, Ana; Alves, Carlos; Mendes, Diogo; Marques, Francisco Batel. "JAK inhibitors for atopic dermatitis: A network meta-analysis of adverse events". Paper presented in 38th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE), 2022.
  4. Penedones, Ana; Mendes, Diogo; Alves, Carlos; Batel-Marques, Francisco. "Numbers needed to treat to benefit (nntb) and to harm (nnth) for COVID-19 medicines". Paper presented in 38th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, 2022.
  5. Abrantes, Joana; Tavares, Inês; Penedones, Ana; Figueiredo, Daniel; Mendes, Diogo; Alves, Carlos; Batel-Marques, Francisco. "The Impact of the COVID-19 Pandemic on Spontaneous Reporting of Adverse Drug Reactions in the Central Region of Portugal". Paper presented in 21st International Society of Pharmacovigilance Annual Meeting, 2022.
  6. Tavares, Inês; Penedones, Ana; Abrantes, Joana; Mendes, Diogo; Codeco, C; Rigueiro, Graça; Alves, Carlos; Batel-Marques, Francisco. "Adverse Reactions Associated with Comirnaty® Among Healthcare Professionals: A Cohort Event Monitoring Study in a Portuguese Hospital". Paper presented in 21st International Society of Pharmacovigilance Annual Meeting, 2022.
  7. Penedones, Ana; Alves, Carlos; Mendes, Diogo; Batel-Marques, Francisco. "JAK inhibitors for atopic dermatitis: A network meta-analysis of adverse event". Paper presented in 38th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, 2022.
  8. Penedones, Ana; Alves, Carlos; Mendes, Diogo; Batel-Marques, Francisco. "RISK OF CARDIOVASCULAR AND VENOUS THROMBOEMBOLISM EVENTS AMONG JAK INHIBITORS USED IN RHEUMATOID ARTHRITIS: A NETWORK META-ANALYSIS OF CLINICAL TRIALS". Paper presented in EACPT Virtual Meeting 2021, 2021.
  9. Penedones, Ana; Alves, Carlos; Mendes, Diogo; Batel-Marques, Francisco. "RISK OF INFECTIONS AMONG JAK INHIBITORS USED IN RHEUMATOID ARTHRITIS: A NETWORK META-ANALYSIS OF CLINICAL TRIALS". Paper presented in EACPT Virtual Meeting 2021, 2021.
  10. Batel-Marques, Francisco; Pereira, Diogo; Mendes, Diogo; Alves, Carlos; Penedones, Ana. "Real-world outcomes versus clinical trials results with dipeptidyl peptidase-4 inhibitors: a systematic review protocol". Paper presented in 13th International Conference on Advanced Technologies & Treatments for Diabetes, 2020.
  11. Alves, Carlos; Mendes, Diogo; Penedones, Ana; Marques, Francisco Batel. "Comparative safety of JAK inhibitors in patients with rheumatoid arthritis: A network meta-analysis of clinical trials". Paper presented in 35th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, 2020.
  12. Alves, Carlos; Mendes, Diogo; Penedones, Ana; Marques, Francisco Batel. "Comparative risk of infections among JAK inhibitors used in rheumatoid arthritis: A network meta-analysis of clinical trials". Paper presented in 35th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, 2020.
  13. Mendes, Diogo; Gomes, Rita; Alves, Carlos; Batel-Marques, Francisco. "Polypharmacy as an independent risk factor for serious adverse drug reactions: A systematic review". Paper presented in 36th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, 2020.
  14. Alves, Carlos; Mendes, Diogo; Penedones, Ana; Batel-Marques, Francisco. "Comparative risk of infections among JAK inhibitors used in rheumatoid arthritis: A network meta-analysis of clinical trials". Paper presented in 36th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, 2020.
  15. Alves, Carlos; Mendes, Diogo; Penedones, Ana; Batel-Marques, Francisco. "Comparative safety of JAK inhibitors in patients with rheumatoid arthritis: A network meta-analysis of clinical trials.". Paper presented in 36th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, 2020.
  16. Mendes, Diogo; Rigueiro, Graça; Silva, Rui Sousa; Penedones, Ana; Alves, Carlos; Sousa, Gabriela; Batel-Marques, Francisco. "A pilot intensive safety surveillance scheme for medicines under additional monitoring used in the treatment of cancer". Paper presented in 19th ISOP Annual Meeting, 2019.
  17. Mendes, Diogo; Penedones, Ana; Alves, Carlos; Rigueiro, Graça; Silva, Rui Sousa; Sousa, Gabriela; Batel-Marques, Francisco. "Intensive safety surveillance of anti- cancer medicines subject to additional monitoring: A pilot study". Paper presented in 35th ICPE Conference, 2019.
  18. Mendes, Diogo; Rigueiro, Graca; Silva, Rui Sousa; Penedones, Ana; Alves, Carlos; Sousa, Gabriela; Marques, Francisco Batel. "Intensive safety surveillance of anticancer medicines subject to additional monitoring: A pilot study". Paper presented in 34th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, 2019.
  19. Alves, Carlos; Mendes, Diogo; Marques, Francisco Batel. "Comparing the Safety of Apixaban, Rivaroxaban and Dabigatran: Indirect Treatments Comparisons Using Real-World Studies". Paper presented in 34th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, 2019.
  20. Alves, Carlos; Mendes, Diogo; Batel-Marques, Francisco. "A comparison of the safety of apixaban, rivaroxaban and dabigatran: an indirect treatment comparison using real-world studies.". Paper presented in 19th International Society of Pharmacovigilance Annual Meeting, 2019.
  21. Penedones, Ana; Alves, Carlos; Ribeiro, Inês; Batel-Marques, Francisco. "Methodological considerations on the recommendations to conduct and report systematic reviews in medical literature: systematic review". Paper presented in ISPOR Europe 2018, 2018.
  22. Ribeiro, Ines; Marques, Francisco Batel; Alves, Carlos. "A systematic review of the methodological quality of economic studies evaluating ophthalmic drugs". Paper presented in 34th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, 2018.
  23. Penedones, Ana; Mendes, Diogo; Alves, Carlos; Batel-Marques, Francisco. "Systematic reviews assessing drug's safety in Ophthalmology". Paper presented in 13th Congress of the European Association for Clinical Pharmacology and Therapeutics, 2017.
  24. Penedones, Ana; Mendes, Diogo; Alves, Carlos; Marques, Francisco Batel. "Systematic Reviews in Ophthalmology: Methodological Considerations". Paper presented in 33rd International Conference on Pharmacoepidemiology and Therapeutic Risk Management, 2017.
  25. Alves, Carlos; Mendes, Diogo; Marques, Francisco Batel. "Mortality and Cardiovascular Events Associated with DDP-4 Inhibitors: A Meta-Analysis of Observational Studies". Paper presented in 33rd International Conference on Pharmacoepidemiology and Therapeutic Risk Management, 2017.
  26. Mendes, D.; Alves, C.; Marques, F. Batel. "Number Needed to Treat to Harm (nnth) to Assess the Risk of Cataracts Associated with Statins in Observational Studies". Paper presented in 17th International Society of Pharmacovigilance Annual Meeting, 2017.
  27. Mendes, Diogo; Alves, Carlos; Marques, Francisco Batel. "Application of the Number Needed to Treat (NNT) in Medical Literature: A Methodological Assessment". Paper presented in 33rd International Conference on Pharmacoepidemiology and Therapeutic Risk Management, 2017.
  28. Alves, Carlos; Mendes, Diogo; Marques, Francisco Batel. "A Cumulative Meta-Analysis Evaluating the Risk of Cataracts Associated with Statins". Paper presented in 33rd International Conference on Pharmacoepidemiology and Therapeutic Risk Management, 2017.
  29. Mendes, Diogo; Alves, Carlos; Batel-Marques, Francisco. "The use of the number needed to treat (NNT) to asses the effects of medicinal interventions: a quality assessment". Paper presented in 13th Congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT), 2017.
  30. Alves, Carlos; Mendes, Diogo; Batel-Marques, Francisco. "Risk of cataracts associated with statins: a cumulative meta-analysis". Paper presented in 13th Congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT), 2017.
  31. Penedones, Ana; Mendes, Diogo; Alves, Carlos; Batel-Marques, Francisco. "Systematic reviews assessing drug's safety in Ophthalmology". Paper presented in 13th Congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT), 2017.
  32. Alves, Carlos; Ribeiro, Inês; Penedones, Ana; Mendes, Diogo; Batel-Marques, Francisco. "A meta-analysis evaluating the risk of ophthalmic adverse events associated wit MEK inhibitors". Paper presented in 16th ISOP Annual Meeting, 2016.
  33. Alves, Carlos; Ribeiro, Inês; Penedones, Ana; Mendes, Diogo; Batel-Marques, Francisco. "Ophthalmic adverse effects in cancer patients treted with MEK inhibitors: a meta-analysis". Paper presented in 32nd ICPE Conference, 2016.
  34. Alves, Carlos; Ribeiro, Inês; Penedones, Ana; Mendes, Diogo; Batel-Marques, Francisco. "Treatment with MEK inhibitors and risk of ocular toxicity: a systematic review and meta-analysis". Paper presented in IV Reunião Científica Anual - Sociedade Portuguesa de Farmácia Clínica e Farmacoterapia, 2016.
  35. Alves, Carlos; Ribeiro, Ines; Penedones, Ana; Mendes, Diogo; Marques, Francisco Batel. "Ophthalmic Adverse Effects In Cancer Patients Treated With MEK Inhibitors: A Meta-Analysis". Paper presented in 32nd International Conference on Pharmacoepidemiology (ICPE) and Therapeutic Risk Management, 2016.
  36. Mendes, Diogo; Alves, Carlos; Marques, Francisco Batel. "Applying The Number Needed To Harm (NNH) to Benefit-Risk (BR) Assessments Of Drugs Withdrawn From The Market Due To Safety Reasons". Paper presented in 32nd International Conference on Pharmacoepidemiology (ICPE) and Therapeutic Risk Management, 2016.
  37. Batel-Marques, Francisco; Penedones, Ana; Alves, Carlos; Mendes, Diogo. "Costs associated with adverse drug events: a systematic review". Paper presented in IV Reunião Cientifica Anual da Sociedade Portuguesa de Farmácia Clínica e Farmacoterapia (SPFCF), 2016.
  38. Ribeiro, Inês; Penedones, Ana; Mendes, Diogo; Alves, Carlos; Batel-Marques, Francisco. "Multiple drug exposure as risk factor for serious adverse drug reactions". Paper presented in IV Reunião Cientifica Anual da Sociedade Portuguesa de Farmácia Clínica e Farmacoterapia (SPFCF), 2016.
  39. Mendes, Diogo; Alves, Carlos; Batel-Marques, Francisco. "Is the number needed to harm a useful metric for the assessment of benefit-risk ratios of drugs? A case study with drugs withdrawn from the EU market due to safety reasons". Paper presented in IV Reunião Cientifica Anual da Sociedade Portuguesa de Farmácia Clínica e Farmacoterapia (SPFCF), 2016.
  40. Penedones, Ana; Ribeiro, Inês; Mendes, Diogo; Alves, Carlos; Batel-Marques, Francisco. "The contribution of community pharmacies to Central Portugal Regional Pharmacovigilance Unit activity". Paper presented in IV Reunião Cientifica Anual da Sociedade Portuguesa de Farmácia Clínica e Farmacoterapia (SPFCF), 2016.
  41. Mendes, Diogo; Alves, Carlos; Batel-Marques, Francisco. "Applying the number needed to harm (NNH) to benefit-risk (BR) assessments of drugs withdrawn from the market due to safety reasons". Paper presented in 32nd International Conference on Pharmacoepidemiology (ICPE) and Therapeutic Risk Management, 2016.
  42. Alves, Carlos; Ribeiro, Inês; Penedones, Ana; Mendes, Diogo; Batel-Marques, Francisco. "Ophthalmic adverse effects in cancer patients treated with MEK inhibitors: a meta-analysis". Paper presented in 32nd International Conference on Pharmacoepidemiology (ICPE) and Therapeutic Risk Management, 2016.
  43. Alves, Carlos; Ribeiro, Inês; Penedones, Ana; Mendes, Diogo; Batel-Marques, Francisco. "A Meta-analysis evaluating the risk of ophthalmic adverse events associated with MEK inhibitors". Paper presented in 16th International Society of Pharmacovigilance (ISoP) Annual Meeting, 2016.
  44. Alves, Carlos; Ribeiro, Inês; Mendes, Diogo; Penedones, Ana; Batel-Marques, Francisco. "Ophthalmic adverse effects in cancer patients treated with MEK inhibitors: a systematic review and meta-analysis". Paper presented in 13th International Symposium on Ocular Pharmacology and Therapeutics (ISOPT) Clinical, 2016.
  45. Alves, Carlos; Penedones, Ana; Mendes, Diogo; Batel-Marques, Francisco. "Fluoroquinolones use and Development of Retinal Detachment: a Systematic Review and Meta-analysis". Paper presented in 31st International Conference on Pharmacoepidemiology and Therapeutic Risk Management, 2015.
  46. Alves, Carlos; Penedones, Ana; Mendes, Diogo; Batel Marques, Francisco. "The efficacy and safety of sodium-glucose cotransporter 2 (SGLT2) inhibitors: a systematic review and meta-analysis". Paper presented in III Reunião Científica Anual - Sociedade Portuguesa de Farmácia Clínica e Farmacoterapia, 2015.
  47. Penedones, Ana; Mendes, Diogo; Alves, Carlos; Batel Marques, Francisco. "Ocular adverse events induced by drugs: a review of the safety alerts issued by health regulatory authorities". Paper presented in III Reunião Científica Anual - Sociedade Portuguesa de Farmácia Clínica e Farmacoterapia, 2015.
  48. Penedones, Ana; Mendes, Diogo; Alves, Carlos; Batel Marques, Francisco. "Ophthalmic adverse reactions induced by drugs: a review of the safety alerts issued by health regulatory authorities". Paper presented in XLV Reunião Anual da Sociedade Portuguesa de Farmacologia, 2015.
  49. Batel-Marques F; Penedones A; Alves C; Mendes D. "Costs of Adverse Drug Events: Systematic Review.". Paper presented in International Society for Pharmacoeconomics and Outcomes Research 18th Annual European Congress, 2015.
    10.1016/j.jval.2015.09.1571
  50. Alves C; Mendes D; Andrade S; Batel MF. "The Benefit of Her-2 Targeted Therapies on Overall Survival of Patients With Metastatic Breast Cancer - A Systematic Review.". Paper presented in International Society For Pharmacoeconomics and Outcomes Research (ISPOR) 17th Annual European Congress, 2015.
    10.1016/j.jval.2014.08.2197
  51. Mendes, D.; Dias, P.; Alves, C.; Batel-Marques, F.. "Antibiotics-Induced Liver Injury: A Pharmacovigilance Study Using a Measure of Disproportionality in a Database of Spontaneously Reported Adverse Events". Paper presented in 15th International Society of Pharmacovigilance Annual Meeting, 2015.
  52. Mendes, D.; Alves, C.; Batel-Marques, F.. "Number Needed to Harm as a Tool for Post-Marketing Drug Safety Evaluation: a Pilot Study with Thiazolidinediones". Paper presented in 15th International Society of Pharmacovigilance (ISoP) Annual Meeting, 2015.
  53. Alves, C.; Penedones, A.; Mendes, D.; Batel Marques, F.. "THE EFFICACY AND SAFETY OF SODIUM-GLUCOSE COTRANSPORTER 2 (SGLT2) INHIBITORS: A SYSTEMATIC REVIEW AND META-ANALYSIS". Paper presented in 12th European Association for Clinical Pharmacology and Therapeutics Congress, 2015.
    10.1016/J.CLINTHERA.2015.05.352
  54. Penedones, A.; Mendes, D.; Alves, C.; Batel-Marques, F.. "Ocular Adverse Drug Events: Analysis of Spontaneous Reports from a Portuguese Regional Pharmacovigilance Database". Paper presented in 15th International Society of Pharmacovigilance (ISoP) Annual Meeting, 2015.
  55. Penedones, A.; Mendes, D.; Alves, C.; Batel Marques, F.. "OCULAR ADVERSE EVENTS INDUCED BY DRUGS: A REVIEW OF THE SAFETY ALERTS ISSUED BY HEALTH REGULATORY AUTHORITIES". Paper presented in 12th European Association for Clinical Pharmacology and Therapeutics Congress, 2015.
    10.1016/J.CLINTHERA.2015.05.350
  56. Mendes, Diogo; Alves, Carlos; Marques, Francisco Batel. "Application of Quantitative Methodologies for Benefit-Risk Assessment: Case Study with Rosiglitazone and Pioglitazone". Paper presented in 31st International Conference on Pharmacoepidemiology and Therapeutic Risk Management, 2015.
  57. Mendes, Diogo; Alves, Carlos; Batel-Marques, Francisco. "Grading safety evidence for benefit/risk assessment: are NSAIDs an example?". Paper presented in III Reunião Científica Anual da Sociedade Portuguesa de Farmácia Clínica e Farmacoterapia (SPFCF), 2015.
  58. Batel-Marques, Francisco; Mendes, Diogo; Alves, Carlos; Penedones, Ana; Dias, Patricia; Martins, Angelina; Santiago, Luiz Miguel; et al. "Unidade de Farmacovigilância do Centro: atividades e resultados". Paper presented in III Reunião Científica Anual - SPFCF, 2015.
  59. Alves, Carlos; Penedones, Ana; Mendes, Diogo; Batel-Marques, Francisco. "A Systematic Review and Meta-Analysis Evaluating the Association between Fluoroquinolones use and Development of Retinal Detachment". Paper presented in 2015 American College of Clinical Pharmacy (ACCP) Virtual Poster Symposium, 2015.
  60. Mendes, Diogo; Alves, Carlos; Batel-Marques, Francisco. "Application of quantitative methodologies for benefit-risk assessment: case study with rosiglitazone and pioglitazone". Paper presented in 31st International Conference on Pharmacoepidemiology (ICPE) & Therapeutic Risk Management, 2015.
  61. Penedones, Ana; Mendes, Diogo; Alves, Carlos; Batel-Marques, Francisco. "Ocular adverse drug events: analysis of spontaneous reports from a Portuguese regional pharmacovigilance database". Paper presented in 15th International Society of Pharmacovigilance (ISoP) Annual Meeting, 2015.
  62. Mendes, Diogo; Alves, Carlos; Batel-Marques, Francisco. "Number needed to harm as a tool for post-marketing drug safety evaluation: a pilot study with thiazolidinediones". Paper presented in 15th International Society of Pharmacovigilance (ISoP) Annual Meeting, 2015.
  63. Mendes, Diogo; Dias, Patricia; Alves, Carlos; Batel-Marques, Francisco. "Antibiotics-induced liver injury: a pharmacovigilance study using a measure of disproportionality in a database of spontaneously reported adverse events". Paper presented in 15th International Society of Pharmacovigilance (ISoP) Annual Meeting, 2015.
  64. Batel Marques, Francisco; Mendes, Diogo; Alves, Carlos; Penedones, Ana; Dias, Patricia; Martins, Angelina; Santiago, Luiz Miguel; et al. "Pharmacovigilance in Portugal: Activity of the Central Pharmacovigilance Unit". Paper presented in 2015 American College of Clinical Pharmacy (ACCP) Virtual Poster Symposium, 2015.
  65. Alves, Carlos; Penedones, Ana; Mendes, Diogo; Batel-Marques, Francisco. "Adverse events associated with canagliflozin mechanism of action: a meta-analysis of randomized clinical trials". Paper presented in 14th ISOP Annual Meeting, 2014.
  66. Penedones, Ana; Alves, Carlos; Batel-Marques, Francisco. "Safety profile of ophthalmic biologics: review of safety data". Paper presented in 30th International Conference on Pharmacoepidemiology (ICPE) & Therapeutic Risk Management, 2014.
  67. Alves, Carlos; Macedo, Ana Filpa; Batel-Marques, Francisco. "The Timing of Safety Regulatory Decisions Compared with Cumulative Meta-Analysis’ Risk Estimates". Paper presented in 30th International Conference on Pharmacoepidemiology (ICPE) & Therapeutic Risk Management, 2014.
  68. Alves, Carlos; Macedo, Ana Filipa; Batel-Marques, Francisco. "Safety alerts issued by regulatory authorities: usefulness of meta-analysis in predicting earlier risks". Paper presented in 2014 American College of Clinical Pharmacy Virtual Poster Symposium, 2014.
  69. Mendes, Diogo; Alves, Carlos; Batel-Marques, Francisco. "Safety profile of adalimumab, etanercept and infliximab: analysis of disproportionalities in a Pharmacovigilance database". Paper presented in 2014 American College of Clinical Pharmacy Virtual Poster Symposium, 2014.
  70. Alves, C.; Macedo, A. F.; Mendes, D.; Batel-Marques, F.. "Drug-Safety Alerts Issued by Regulatory Authorities: Usefulness of Meta-Analysis in Predicting Earlier Risks". Paper presented in 14th International Society Of Pharmacovigilance (ISoP) Annual Meeting, 2014.
  71. Alves, Carlos; Macedo, Ana F.; Marques, Francisco Batel. "The Timing of Safety Regulatory Decisions Compared with Cumulative Meta-Analysis' Risk Estimates". Paper presented in 30th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, 2014.
  72. Alves, Carlos; Macedo, Ana Filipa; Batel-Marques, Francisco. "Safety alerts issued by regulatory authorities: usefulness of meta-analysis in predicting earlier risks". Paper presented in 2014 American College of Clinical Pharmacy Virtual Porter Symposium, 2014.
  73. Penedones, Ana; Alves, Carlos; Marques, Francisco Batel. "Safety Profile of Ophthalmic Biologics: Review of Safety Data". Paper presented in 30th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, 2014.
  74. Mendes, Diogo; Alves, Carlos; Marques, Francisco Batel. "Cases of Anaphylaxis Associated with the Use of Drugs: Analysis of a Pharmacovigilance Database". Paper presented in 30th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, 2014.
  75. Mendes, Diogo; Alves, Carlos; Batel-Marques, Francisco. "Cases of anaphylaxis associated with the use of drugs: analysis of a Pharmacovigilance database". Paper presented in 30th International Conference on Pharmacoepidemiology (ICPE) & Therapeutic Risk Management, 2014.
  76. Alves, Carlos; Macedo, Ana Filipa; Mendes, Diogo; Batel-Marques, Francisco. "Drug-safety alerts issued by regulatory authorities: usefulness of meta-analysis in predicting earlier risks". Paper presented in 14th International Society Of Pharmacovigilance (ISoP) Annual Meeting, 2014.
  77. Mendes, Diogo; Alves, Carlos; Andrade, Sofia; Batel-Marques, Francisco. "The benefit of HER-2 targeted therapies on overall survival of patients with metastatic cancer - a systematic review". Paper presented in International Society For Pharmacoeconomics and Outcomes Research (ISPOR) 17th Annual European Congress, 2014.
  78. Alves, Carlos; Macedo, Ana Filipa; Batel-Marques, Francisco. "Data sources used by regulatory agencies on the generation of drug safety alert". Paper presented in 13th International Society of Pharmacovigilance Annual Meeting, 2013.
  79. Alves, Carlos; Macedo, Ana Filipa; Mendes, Diogo; Fontes Ribeiro, Carlos; Batel-Marques, Francisco. "Statin therapy and incidence of cataracts: a meta-analysis". Paper presented in 13th International Society of Pharmacovigilance Annual Meeting, 2013.
  80. Barata, Inês; Alves, Carlos; Mendes, Diogo; Fontes Ribeiro, Carlos; Batel-Marques, Francisco. "The preventability of adverse drug reactions occurring with antineoplastic drugs – an evaluation of spontaneously reported cases". Paper presented in 13th International Society of Pharmacovigilance Annual Meeting, 2013.
  81. Alves, Carlos; Macedo, Ana Filipa; Batel-Marques, Francisco. "Statin therapy and incident cataract: a meta-analysis". Paper presented in 29th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, 2013.
  82. Alves, Carlos; Macedo, Ana Filipa; Batel-Marques, Francisco. "Data sources supporting safety warnings and the correspondence scientific evidence published in literature: a descriptive study". Paper presented in 29th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, 2013.
  83. Alves, Carlos; Macedo, Ana F.; Marques, Francisco Batel. "Data Sources Supporting Safety Warnings and the Correspondence Scientific Evidence Published in Literature: A Descriptive Study". Paper presented in 29th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, 2013.
  84. Barata, I.; Alves, C.; Mendes, D.; Fontes Ribeiro, C.; Batel Marques, F.. "The Preventability of Adverse Drug Reactions Occurring With Antineoplastic Drugs-An Evaluation of Spontaneously Reported Cases". Paper presented in 13th International Society of Pharmacovigilance Annual Meeting, 2013.
  85. Alves, C.; Macedo, A. F.; Mendes, D.; Fontes Ribeiro, C.; Batel Marques, F.. "Statin Therapy and Incidence of Cataracts: A Meta-Analysis". Paper presented in 13th International Society of Pharmacovigilance Annual Meeting, 2013.
  86. Alves, Carlos; Macedo, Ana F.; Mendes, Diogo; Marques, Francisco Batel. "Statin Therapy and Incident Cataract: A Meta-Analysis". Paper presented in 29th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, 2013.
  87. Alves, Carlos; Macedo, Ana Filipa; Batel-Marques, Francisco. "Acute Pancreatitis Associated with GLP-1 Agonists (Exenatide and Liraglutide) Exposure: A Meta-Analysis of Published Evidence". Paper presented in 28th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, 2012.
  88. Batel-Marques, Francisco; Alves, Carlos; Mendes, Diogo; Fontes-Ribeiro, Carlos. "Severity of Adverse Drug Reactions Reported from Hospitals and Ambulatory Care Settings in Central Portugal: An Update". Paper presented in 28th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, 2012.
  89. Alves, Carlos; Batel-Marques, Francisco. "Acute pancreatitis associated with GLP-1 Agonists (Exenatide and Liraglutide) exposure: a meta-analysis of published randomized controlled clinical trials". Paper presented in 2012 American College of Clinical Pharmacy Virtual Porter Symposium, 2012.
  90. Mendes, Diogo; Alves, Carlos; Fontes-Ribeiro, Carlos; Batel-Marques, Francisco. "Ten Years of Activity of the Regional Pharmacovigilance Unit of Central Portugal and Its Contribution for Drug Safety Knowledge". Paper presented in 28th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, 2012.
  91. Alves, Carlos; Macedo, Ana Filipa; Batel-Marques, Francisco. "GLP-1 Agonists (Exenatide and Liraglutide) and the Risk of Cancer: A Meta-Analysis of Published Randomized Controlled Clinical Trials". Paper presented in 28th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, 2012.
  92. Alves, Carlos; Batel Marques, Francisco; Macedo, Ana Filipa. "The risk of acute pancreatitis and cancer associated with GLP-1 agonists, exenatide and liraglutide: a meta-analysis of published evidence". Paper presented in 6th European Congress of Pharmacology, 2012.
  93. Mendes, Diogo; Alves, Carlos; Fontes Ribeiro, Carlos; Batel-Marques, Francisco. "Spontaneous reporting of adverse drug reactions: a tem years' contribution of the activity of the Regional Pharmacovigilance Unit of Central Portugal for drug safety knowledge". Paper presented in 6th European Congress of Pharmacology, 2012.
  94. Mendes, Diogo; Alves, Carlos; Fontes Ribeiro, Carlos; Batel-Marques, Francisco. "Ten years of activity of the regional pharmacovigilance unit of central portugal and its contribution for drug safety knowledge". Paper presented in 28th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, 2012.
  95. Craveiro, Nuno; Alves, Carlos; Fontes Ribeiro, Carlos; Batel-Marques, Francisco. "Sources of information supporting drug withdrawal from the market due to safety reasons". Paper presented in 28th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, 2012.
  96. Batel-Marques, Francisco; Alves, Carlos; Mendes, Diogo; Fontes Ribeiro, Carlos. "Severity of adverse drug reactions reported from hospitals and ambulatory care settings in central Portugal: an update". Paper presented in 28th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, 2012.
  97. Alves, Carlos; Macedo, Ana Filipa; Batel-Marques, Francisco. "GLP-1 agonists (exenatide and liraglutide) and the risk of cancer: a meta-analysis of published randomized controlled clinical trials". Paper presented in 28th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, 2012.
  98. Alves, Carlos; Macedo, Ana Filipa; Batel-Marques, Francisco. "Acute pancreatitis associated with GLP-1 agonists (exenatide and liraglutide) exposure: a meta-analysis of published evidence". Paper presented in 28th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, 2012.
  99. Craveiro, Nuno; Alves, Carlos; Fontes-Ribeiro, Carlos; Batel-Marques, Francisco. "Sources of Information Supporting Drug Withdrawal from the Market Due to Safety Reasons". Paper presented in 28th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, 2012.
  100. Mendes, Diogo; Alves, Carlos; Fontes Ribeiro, Carlos; Batel-Marques, Francisco. "Spontaneous reporting of adverse drug reactions: a ten years' contribution of the activity of the Regional Pharmacovigilance Unit of Central Portugal for drug safety knowledge". Paper presented in 6th European Congress of Pharmacology, 2012.
  101. Marques, Francisco Batel; Alves, Carlos; Craveiro, Nuno; Ribeiro, Carlos Fontes; Macedo, Ana Filipa. "Increased Severity of Adverse Drug Reactions Reported from Hospitals". Paper presented in 27th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, 2011.
  102. Craveiro, Nuno; Alves, Carlos; Ribeiro, Carlos Fontes; Marques, Francisco Batel. "Hypersensitivity Syndrome Due to Drug Exposure - Ten Years Case Review". Paper presented in 27th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, 2011.
  103. Craveiro, Nuno; Alves, Carlos; Ribeiro, Carlos Fontes; Marques, Francisco Batel. "Methods for Disproportionality Analysis: Testing a Bayesian with a Non Bayesian Method". Paper presented in 27th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, 2011.
  104. Alves, Carlos; Batel-Marques, Francisco; Craveiro, Nuno; Macedo, Ana Filipa. "Revisão das fontes de informação utilizadas em meta-análises de segurança". Paper presented in 10º Congresso da Associação Nacional das Farmácias, 2011.
  105. Craveiro, Nuno; Alves, Carlos; Fontes Ribeiro, Carlos; Batel-Marques, Francisco. "Farmacovigilância - Contributo dos farmacêuticos na região centro nos últimos 10 anos". Paper presented in 10º Congresso da Associação Nacional de Farmácias, 2011.
  106. Alves, Carlos; Macedo, Ana Filipa; Craveiro, Nuno; Batel-Marques, Francisco. "Safety evaluation of pharmacological interventions: a review of recent published meta-analysis". Paper presented in 27th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 2011.
  107. Batel-Marques, Francisco; Alves, Carlos; Craveiro, Nuno; Fontes Ribeiro, Carlos; Macedo, Ana Filipa. "Increased severity of adverse drug reactions reported from hospitals". Paper presented in 27th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, 2011.
  108. Craveiro, Nuno; Alves, Carlos; Fontes Ribeiro, Carlos; Batel-Marques, Francisco. "Methods for disproportionality analysis: testing a bayesian with a non bayesian method". Paper presented in 27th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 2011.
  109. Craveiro, Nuno; Alves, Carlos; Fontes Ribeiro, Carlos; Batel-Marques, Francisco. "Hypersensitivity syndrome due to drug exposure - ten years case review". Paper presented in 27th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 2011.
  110. Mendes, Diogo; Alves, Carlos; Batel Marques, Francisco. "Unidade de Farmacovigilância do Centro: estudo da casuística". Paper presented in Conferência do Centro de Estudos Farmacêuticos 2011, 2011.
  111. Craveiro, Nuno; Alves, Carlos; Fontes Ribeiro, Carlos; Batel-Marques, Francisco. "Reported cases of hypersensitivity syndrome due to medicines exposure in central Portugal pharmacovigilance unit: ten years case review". Paper presented in Conferência do Centro de Estudos Farmacêuticos 2011, 2011.
  112. Alves, Carlos; Macedo, Ana Filipa; Batel-Marques, Francisco. "Safety profile of Xa coagulation factor direct inhibitors after hip and knee arthroplasty: a meta-analysis". Paper presented in Conferência do Centro de Estudos Farmacêuticos 2011, 2011.
  113. Alves, Carlos; Macedo, Ana Filipa; Craveiro, Nuno; Marques, Francisco Batel. "Safety Evaluation of Pharmacological Interventions: A Review of Recent Published Meta-Analysis". Paper presented in 26th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, 2010.
  114. Craveiro, Nuno; Alves, Carlos; Batel-Marques, Francisco. "Differences in Causality Assessments of Adverse Drug Reactions According to the Reports from Different Professional Groups". Paper presented in 26th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, 2010.
  115. Craveiro, Nuno; Alves, Carlos; Batel-Marques, Francisco. "Differences in causality of adverse drug reactions according to the reports from different professional groups". Paper presented in 26th International Conference on Pharmacoepidemiology and Risk Management, 2010.
Journal article
  1. Carlos Alves; Diogo Mendes; Ana Penedones; Tânia Oliveira; António Donato; Francisco Batel-Marques. "The effectiveness of ibandronate in reducing the risk of nonvertebral fractures in women with osteoporosis: systematic review and meta-analysis of observational studies". International Journal of Clinical Pharmacy (2024): https://doi.org/10.1007/s11096-023-01666-x.
    10.1007/s11096-023-01666-x
  2. Figueiredo D; Ribeiro I; Penedones A; Mendes D; Alves C; Batel-Marques F; da Silva DP. "Correction: Performance of Aptima-HPV in the cervical cancer screening program of Portugal: a cost-analysis.". BMC women's health (2024): http://europepmc.org/abstract/med/38331784.
    10.1186/s12905-024-02927-1
  3. Mendes D; Figueiredo D; Alves C; Penedones A; Costa B; Batel-Marques F. "Impact of the Covid-19 Pandemic on Cancer Screenings in Portugal". Cancer epidemiology (2023): http://europepmc.org/abstract/PPR/PPR721470.
    10.2139/ssrn.4554335
  4. Carlos Alves; Ana Penedones; Diogo Mendes; Francisco Batel Marques. "Topical Janus kinase inhibitors in atopic dermatitis: a safety network meta-analysis". International Journal of Clinical Pharmacy (2023): https://doi.org/10.1007/s11096-023-01569-x.
    10.1007/s11096-023-01569-x
  5. Figueiredo D; Ribeiro I; Penedones A; Mendes D; Alves C; Batel-Marques F; da Silva DP. "Performance of Aptima-HPV in the cervical cancer screening program of Portugal: a cost-analysis.". BMC women's health (2023): http://europepmc.org/abstract/med/36894908.
    10.1186/s12905-023-02219-0
  6. Mendes, Diogo; Alves, Carlos; Penedones, Ana; Costa, Beatriz; Batel Marques, Francisco. "The European Health Technology Assessment Regulation and its Potential Impact on Access to the Medicines Market: What do Professionals in the Field Think?". (2023): https://doi.org/10.25756/rpf.v15i1-2.310.
    https://doi.org/10.25756/rpf.v15i1-2.310
  7. Carlos Alves; Ana Penedones; Diogo Mendes; Francisco Batel Marques. "The safety of systemic Janus kinase inhibitors in atopic dermatitis: a systematic review and network meta-analysis". European Journal of Clinical Pharmacology (2022): https://doi.org/10.1007/s00228-022-03400-4.
    10.1007/s00228-022-03400-4
  8. Mendes D; Penedones A; Alves C; Oliveira T; Donato A; Batel-Marques F. "Ibandronate in the Prevention of Vertebral and Nonvertebral Osteoporotic Fractures: A Systematic Review of Experimental and Observational Studies.". Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases (2022): http://europepmc.org/abstract/med/36731043.
    10.1097/rhu.0000000000001902
  9. Alves C; Penedones A; Mendes D; Marques FB. "The Risk of Infections Associated With JAK Inhibitors in Rheumatoid Arthritis: A Systematic Review and Network Meta-analysis.". Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases (2022): http://europepmc.org/abstract/med/33902098.
    10.1097/rhu.0000000000001749
  10. Alves C; Penedones A; Mendes D; Marques FB. "Risk of Cardiovascular and Venous Thromboembolic Events Associated With Janus Kinase Inhibitors in Rheumatoid Arthritis: A Systematic Review and Network Meta-analysis.". Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases (2022): http://europepmc.org/abstract/med/34741000.
    10.1097/rhu.0000000000001804
  11. Diogo Mendes; Ana Penedones; Michele Martins; Susana Cavadas; Carlos Alves; Francisco Batel-Marques. "Rectus sheath hematoma in patients receiving subcutaneous enoxaparin: A case series of five patients". Clinical Case Reports 8 12 (2020): 3432-3439. https://doi.org/10.1002/ccr3.3427.
    10.1002/ccr3.3427
  12. Alves C; Penedones A; Mendes D; Batel-Marques F. "Risk of infections and cardiovascular and venous thromboembolic events associated with JAK inhibitors in rheumatoid arthritis: protocols of two systematic reviews and network meta-analyses.". BMJ open (2020): http://europepmc.org/abstract/med/33384392.
    10.1136/bmjopen-2020-041420
  13. Mendes D; Abrantes J; Rigueiro G; Pais AF; Penedones A; Alves C; Batel-Marques F. "Real-world intensive safety monitoring of biosimilars rituximab and trastuzumab in a Portuguese oncology hospital.". Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2020): http://europepmc.org/abstract/med/32936721.
    10.1177/1078155220957079
  14. Ribeiro I; Batel Marques F; Mendes D; Alves C. "A Systematic Review of Economic Studies Evaluating Ophthalmic Drugs: An Analysis of the Health-state Utilities.". Ophthalmic epidemiology (2020): http://europepmc.org/abstract/med/32691652.
    10.1080/09286586.2020.1792938
  15. Mendes D; Oliveira AR; Alves C; Batel Marques F. "Spontaneous reports of hypersensitivity adverse drug reactions in Portugal: a retrospective analysis.". Expert opinion on drug safety (2020): http://europepmc.org/abstract/med/32167395.
    10.1080/14740338.2020.1743262
  16. Ribeiro I; Batel Marques F; Alves D; Alves C. "An analysis of the effectiveness outcomes of economic studies evaluating ophthalmic drugs: a systematic review.". Acta ophthalmologica (2020): http://europepmc.org/abstract/med/32003153.
    10.1111/aos.14362
  17. Mendes, Diogo; Rigueiro, Graca; Silva, Rui Sousa; Penedones, Ana; Alves, Carlos; Sousa, G; Batel-Marques, Francisco. "Intensive safety monitoring program of antineoplastic medicines: A pilot study in a Portuguese oncology hospital". Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2020): https://doi.org/10.1177/1078155219849277.
    10.1177/1078155219849277
  18. Carlos Alves; Diogo Mendes; Francisco Batel Marques. "Fluoroquinolones and the risk of tendon injury: a systematic review and meta-analysis". European Journal of Clinical Pharmacology 75 10 (2019): 1431-1443. https://doi.org/10.1007/s00228-019-02713-1.
    10.1007/s00228-019-02713-1
  19. Mendes D; Alves C; Silverio N; Batel Marques F. "Prevalence of Undiagnosed Hypothyroidism in Europe: A Systematic Review and Meta-Analysis.". European thyroid journal (2019): http://europepmc.org/abstract/med/31259155.
    10.1159/000499751
  20. Penedones, Ana; Alves, Carlos; Batel-Marques, Francisco. "A comparison between two recommendations to conduct and report systematic reviews on drug's safety". Systematic reviews 8 1 (2019): 238. http://europepmc.org/articles/PMC6796334.
    10.1186/s13643-019-1167-5
  21. Batel-Marques, Francisco; Pereira, Diogo; Mendes, Diogo; Alves, Carlos; Penedones, Ana. "Effectiveness in clinical practice versus efficacy of dipeptidyl peptidase-4 inhibitors in clinical trials for type 2 diabetes: protocol for systematic review". BMJ open (2019): http://europepmc.org/articles/PMC6756359.
    10.1136/bmjopen-2019-032522
  22. Alves, Carlos. "Risk of nonarteritic ischaemic optic neuropathy with phosphodiesterase type 5 inhibitors: a systematic review and meta-analysis". Acta ophthalmologica (2019): https://doi.org/10.1111/aos.14253.
    10.1111/aos.14253
  23. Alves, Carlos. "A systematic review of the methodological quality of economic studies evaluating ophthalmic drugs". Expert review of pharmacoeconomics & outcomes research (2019): https://doi.org/10.1080/14737167.2019.1579646.
    10.1080/14737167.2019.1579646
  24. Penedones, Ana; Alves, Carlos; Batel-Marques, Francisco. "Recommendations to conduct and report systematic reviews in medical literature: a scoping review". BMC medical research methodology 19 1 (2019): 234. https://europepmc.org/articles/PMC6907169.
    10.1186/s12874-019-0870-1
  25. Mendes, Diogo; Alves, Carlos; Batel Marques, Francisco. "Safety of Oral Antidiabetics: A Disproportionality Analysis in the Portuguese Pharmacovigilance System". Revista Portuguesa de Farmacoterapia 11 2-3 (2019): 20-30. https://doi.org/10.25756/rpf.v11i2-3.217.
    https://doi.org/10.25756/rpf.v11i2-3.217
  26. Alves, Carlos; Mendes, Diogo; Batel Marques, Francisco. "Risk of tendinopahty associated with fluoroquinolones: A systematic review and meta-analysis". Pharmacoepidemiology and Drug Safety (2019): https://publons.com/wos-op/publon/49303997/.
  27. Ribeiro, Ines; Marques, Francisco Batel; Alves, Carlos. "An analysis of the effectiveness outcomes of economic studies evaluating ophthalmic drugs: A systematic review". Pharmacoepidemiology and Drug Safety (2019): https://publons.com/wos-op/publon/49303996/.
  28. Alves C; Mendes D; Batel Marques F. "Statins and risk of cataracts: a systematic review and meta-analysis of observational studies.". Cardiovascular therapeutics 36 6 (2018): e12480. http://europepmc.org/abstract/med/30597753.
    10.1111/1755-5922.12480
  29. Mendes D; Alves C; Loureiro M; Fonte A; Batel-Marques F. "Drug-induced hypersensitivity: A 5-year retrospective study in a hospital electronic health records database.". Journal of clinical pharmacy and therapeutics (2018): http://europepmc.org/abstract/med/30069891.
    10.1111/jcpt.12752
  30. Mendes D; Alves C; Batel-Marques F. "Number needed to treat (NNT) in clinical literature: an appraisal.". BMC medicine (2017): http://europepmc.org/abstract/med/28571585.
    10.1186/s12916-017-0875-8
  31. Alves C; Ribeiro I; Penedones A; Mendes D; Batel Marques F. "Risk of Ophthalmic Adverse Effects in Patients Treated with MEK Inhibitors: A Systematic Review and Meta-Analysis.". Ophthalmic research 57 1 (2017): 60-69. http://europepmc.org/abstract/med/27404571.
    10.1159/000446845
  32. Batel-Marques F; Penedones A; Mendes D; Alves C. "Outcomes From the First 6 Years of Operation of the Central Portugal Pharmacovigilance Unit.". Journal of patient safety (2016): http://europepmc.org/abstract/med/27997457.
    10.1097/pts.0000000000000273
  33. Mendes D; Alves C; Batel-Marques F. "Benefit-Risk of Therapies for Relapsing-Remitting Multiple Sclerosis: Testing the Number Needed to Treat to Benefit (NNTB), Number Needed to Treat to Harm (NNTH) and the Likelihood to be Helped or Harmed (LHH): A Systematic Review and Meta-Analysis.". CNS drugs (2016): http://europepmc.org/abstract/med/27538416.
    10.1007/s40263-016-0377-9
  34. Batel Marques F; Penedones A; Mendes D; Alves C. "A systematic review of observational studies evaluating costs of adverse drug reactions.". ClinicoEconomics and outcomes research : CEOR (2016): http://europepmc.org/abstract/med/27601925.
    10.2147/CEOR.S115689
  35. Mendes D; Alves C; Batel Marques F. "Testing the usefulness of the number needed to treat to be harmed (NNTH) in benefit-risk evaluations: case study with medicines withdrawn from the European market due to safety reasons.". Expert opinion on drug safety (2016): http://europepmc.org/abstract/med/27467204.
    10.1080/14740338.2016.1217989
  36. Alves C; Penedones A; Mendes D; Batel Marques F. "A systematic review and meta-analysis of the association between systemic fluoroquinolones and retinal detachment.". Acta ophthalmologica (2016): http://europepmc.org/abstract/med/26846201.
    10.1111/aos.12931
  37. Mendes D; Alves C; Afonso N; Cardoso F; Passos-Coelho JL; Costa L; Andrade S; Batel-Marques F. "The benefit of HER2-targeted therapies on overall survival of patients with metastatic HER2-positive breast cancer--a systematic review.". Breast cancer research : BCR (2015): http://europepmc.org/abstract/med/26578067.
    10.1186/s13058-015-0648-2
  38. Mendes D; Alves C; Batel-Marques F. "Number needed to harm in the post-marketing safety evaluation: results for rosiglitazone and pioglitazone.". Pharmacoepidemiology and drug safety (2015): http://europepmc.org/abstract/med/26376779.
    10.1002/pds.3874
  39. Penedones A; Mendes D; Alves C; Marques FB. "Drug-induced ocular adverse reactions: review of the safety alerts issued during the last decade.". Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics (2015): http://europepmc.org/abstract/med/25871404.
    10.1089/jop.2014.0165
  40. Dias P; Penedones A; Alves C; Ribeiro CF; Marques FB. "The Role of Disproportionality Analysis of Pharmacovigilance Databases in Safety Regulatory Actions: a Systematic Review.". Current drug safety (2015): http://europepmc.org/abstract/med/26219291.
    10.2174/1574886310666150729112903
  41. Batel-Marques, F.; Mendes, D.; Alves, C.; Penedones, A.; Dias, P.; Martins, A.; Santiago, L.M.; et al. "Pharmacovigilance in Portugal: Activity of the Central Pharmacovigilance Unit,Farmacovigilância em Portugal: Atividade da Unidade Regional do Centro". Acta Medica Portuguesa 28 2 (2015): 222-232. http://www.scopus.com/inward/record.url?eid=2-s2.0-84930428460&partnerID=MN8TOARS.
  42. Alves, Carlos; Penedones, Ana; Mendes, Diogo; Marques, Francisco Batel. "Fluoroquinolones Use and Development of Retinal Detachment: A Systematic Review and Meta-analysis". Pharmacoepidemiology and Drug Safety (2015): https://publons.com/wos-op/publon/49304018/.
  43. Batel Marques, Francisco; Mendes, Diogo; Alves, Carlos; Penedones, Ana; Dias, Patricia; Martins, Angelina; Santiago, Luiz Miguel; et al. "Farmacovigilância em Portugal: Atividade da Unidade Regional do Centro". Acta Médica Portuguesa 28 2 (2015): 222-222.
    Published • 10.20344/amp.5717
  44. Penedones, Ana; Mendes, Diogo; Alves, Carlos; Batel Marques, Francisco. "Segurança dos Medicamentos Biológicos Oftálmicos: Revisão Sistemática". Revista Portuguesa de Farmacoterapia 7 1 (2015): 28-44.
    Published
  45. Penedones A; Mendes D; Alves C; Batel Marques F. "Safety monitoring of ophthalmic biologics: a systematic review of pre- and postmarketing safety data.". Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics (2014): http://europepmc.org/abstract/med/25073069.
    10.1089/jop.2013.0206
  46. Mendes, Diogo; Alves, Carlos; Batel Marques, Francisco. "Nurses' spontaneous reporting of adverse drug reactions: expert review of routine reports". Journal of Nursing Management 22 3 (2014): 322-330.
    Published • 10.1111/jonm.12003
  47. Mendes, Diogo; Alves, Carlos; Batel Marques, Francisco. "Safety profiles of adalimumab, etanercept and infliximab: a pharmacovigilance study using a measure of disproportionality in a database of spontaneously reported adverse events". Journal of Clinical Pharmacy and Therapeutics 39 3 (2014): 307-313.
    Published • 10.1111/jcpt.12148
  48. Alves, Carlos; Batel Marques, Francisco; Macedo, Ana Filipa. "Drug-safety alerts issued by regulatory authorities: usefulness of meta-analysis in predicting risks earlier". European Journal of Clinical Pharmacology 0 0 (2014): 0-0.
    Published • 10.1007/s00228-014-1670-5
  49. Mendes, Diogo; Alves, Carlos; Batel-Marques, Francisco. "Safety profile of adalimumab, etanercept and infliximab: analysis of disproportionalities in a Pharmacovigilance database". Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy (2014): https://publons.com/wos-op/publon/49304030/.
  50. Alves, Carlos; Macedo, Ana Filipa; Batel-Marques, Francisco. "Sources of information used by regulatory agencies on the generation of drug safety alerts". European Journal of Clinical Pharmacology 69 12 (2013): 2083-2094.
    Published • 10.1007/s00228-013-1564-y
  51. Mendes, Diogo; Alves, Carlos; Batel Marques, Francisco. "Safety of biologics approved for treating rheumatoid arthritis: analysis of spontaneous reports of adverse events". Clinical Rheumatology 32 8 (2013): 1207-1214.
    Published • 10.1007/s10067-013-2256-9
  52. Mendes, Diogo; Alves, Carlos; Batel Marques, Francisco. "Iatrogenia grave desconhecida, notificações e notificadores: resultados da actividade da Unidade de Farmacovigilância do Centro". Revista Portuguesa de Medicina Geral e Familiar 28 1 (2012): 34-40.
    Published
  53. Alves, Carlos. "Acute pancreatitis associated with exenatide and liraglutide: a meta-analysis". Revista Portuguesa de Farmacoterapia 4 3 (2012): 187-197.
    Published
  54. Alves, Carlos; Batel-Marques, Francisco; Macedo, Ana Filipa. "A meta-analysis of serious adverse events reported with exenatide and liraglutide: Acute pancreatitis and cancer". Diabetes Research and Clinical Practice 98 2 (2012): 271-284.
    Published • 10.1016/j.diabres.2012.09.008
  55. Alves C; Batel-Marques F; Macedo AF. "Apixaban and rivaroxaban safety after hip and knee arthroplasty: a meta-analysis.". Journal of cardiovascular pharmacology and therapeutics (2011): http://europepmc.org/abstract/med/22134134.
    10.1177/1074248411427402
  56. Alves C; Batel-Marques F; Macedo AF. "Data sources on drug safety evaluation: a review of recent published meta-analyses.". Pharmacoepidemiology and drug safety (2011): http://europepmc.org/abstract/med/22025370.
    10.1002/pds.2260
  57. Macedo, Ana Filipa; Alves, Carlos; Craveiro, Nuno; MARQUES, FRANCISCO BATEL. "Multiple drug exposure as a risk factor for the seriousness of adverse drug reactions". Journal of Nursing Management 19 3 (2011): 395-399.
    Published • 10.1111/j.1365-2834.2011.01216.x
  58. Craveiro, Nuno; Alves, Carlos; Batel Marques, Francisco. "Níveis de causalidade imputados a reacções adversas a medicamentos em função do profissional notificador: potencial influência do acesso à informação clínica". Revista Portuguesa de Farmacoterapia 2 2 (2010): 89-93.
    Published
  59. Macedo, Ana Filipa; Alves, Carlos; Craveiro, Nuno; Batel Marques, Francisco. "A exposição simultânea a vários medicamentos como factor de risco de reacções adversas graves". Revista Portuguesa de Farmacoterapia 2 3 (2010): 163-166.
    Published
  60. Alves, Carlos; Craveiro, Nuno; Batel Marques, Francisco. "O papel dos farmacêuticos na farmacovigilância". Revista da Ordem dos Farmacêuticos - (2010): 0-0.
    Published
Newsletter article
  1. Batel-Marques, Francisco; Penedones, Ana; Alves, Carlos; Mendes, Diogo. "Métodos de Síntese de Evidência Científica.", Revista da Ordem dos Farmacêuticos. Boletim do CIM. Janeiro-Março 2023. ISSN: 2184-9072, 2023, https://www.ordemfarmaceuticos.pt/pt/publicacoes/boletim-do-cim/boletim-do-cim-jan-mar-2023/.
  2. Alves, Carlos; Mendes, Diogo; Batel-Marques, Francisco. "O papel da avaliação económica na seleção de medicamentos", Revista da Ordem dos Farmacêuticos. Boletim do CIM. Janeiro-Março 2019. , 2019, https://www.ordemfarmaceuticos.pt/pt/publicacoes/boletim-do-cim/boletim-do-cim-jan-mar-2019/.

Other

Other output
  1. FARMACOVIGILÂNCIA - Atualizações de segurança de medicamentos. 2014. Macedo, Tice; Penedones, Ana; Mendes, Diogo; Alves, Carlos; Fontes Ribeiro, Carlos; Batel Marques, Francisco.
Activities

Oral presentation

Presentation title Event name
Host (Event location)
2024/02 Characterization of the comparisons established among relative effectiveness assessments in health technologies assessment LIV Reunião da Sociedade Portuguesa de Farmacologia
2024/02 Medication wastage in residential care homes for the elderly: a pilot study in central Portugal LIV Reunião da Sociedade Portuguesa de Farmacologia
2023 P10 Impact of the COVID-19 Pandemic on Cancer Screenings in Portugal and Years of Life Lost Due to Delayed Diagnoses ISPOR Europe 2023
2021/08 JAK inhibitors and the risk of cardiovascular and venous thromboembolism events among patients with rheumatoid arthritis: A network meta-analysis of clinical trials 37th International Conference on Pharmacoepidemiology and Therapeutic Risk Management
2020 To conduct and report systematic reviews on drug’s safety: comparison between two recommendations L Reunião Anual da Sociedade Portuguesa de Farmacologia
2020 A comparison between the effectiveness in clinical practice versus the efficacy in clinical trials of dipeptidyl peptidase-4 inhibitors for type 2 diabetes: protocol for systematic review L Reunião Anual da Sociedade Portuguesa de Farmacologia
2019/01/25 PASS studies (Post – authorization safety studies) PharmV Onco Pharmacovigilance Conference
2019 Intensive drug safety monitoring program: results of a pilot study in a portuguese oncology hospital XLVIX Reunião Anual da Sociedade Portuguesa de Farmacologia
2018/02 Recommendations to conduct and report systematic reviews in medical literature: systematic review XLVIII Reunião Anual da Sociedade Portuguesa de Farmacologia
2017 Systematic reviews in ophthalmology: methodological considerations XLVII Reunião Anual da Sociedade Portuguesa de Farmacologia
2016/02 Risk of ophthalmic adverse effects in cancer patients treated with MEK inhibithors: a systematic review and meta-analysis XLVI Reunião Anual da Sociedade Portuguesa de Farmacologia
2016 Pharmacovigilance outcomes over a six years period of time: an update XLVI Reunião Anual da Sociedade Portuguesa de Farmacologia
2015/02 Systematic review and meta-analysis on the efficacy and safety of sodium-glucose cotransporter 2 (SGLT2) inhibitors. XLV Reunião Anual da Sociedade Portuguesa de Farmacologia
2015 Quantitative benefit-risk assessment using NNT, NNH, and LHH: a case study with rosiglitazone XLV Reunião Anual da Sociedade Portuguesa de Farmacologia
2015 Unidade de Farmacovigilância do Centro: atividades e resultados. XLV Reunião Anual da Sociedade Portuguesa de Farmacologia
2015 Grading safety evidence for benefit/risk assessment: are NSAIDs na example. XLV Reunião Anual da Sociedade Portuguesa de Farmacologia
2015 Ophthalmic adverse reactions induced by drugs: a review of the safety alerts issued by health regulatory authorities XLV Reunião Anual da Sociedade Portuguesa de Farmacologia
2013 Risk of infections and tuberculosis associated with adalimumab, etanercept and infliximab: analysis of spontaneously reported adverse drug reactions in Portugal 13th International Society of Pharmacovigilance Annual Meeting
International Society of Pharmacovigilance (Pisa, Italy)
2012 Bleeding safety profile of apixaban and rivaroxaban after hip and knee arthroplasty: a meta-analysis XLII Reunião Anual da Sociedade Portuguesa de Farmacologia
Sociedade Portuguesa de Farmacologia (Lisboa, Portugal)
2012 Meta-analysis as a pharmacovigilance tool: experimental and observational studies as data sources XLII Reunião Anual da Sociedade Portuguesa de Farmacologia
Sociedade Portuguesa de Farmacologia (Lisboa, Portugal)
2012 Acute pancreatitis associated with GLP-1 agonists (exenatide and liraglutide) exposure: a meta-analysis of published randomized controlled trials XLII Reunião Anual da Sociedade Portuguesa de Farmacologia
Sociedade Portuguesa de Farmacologia (Lisboa, Portugal)
2012 Adverse drug reaction spontaneous reporting: results of ten years of activity of the regional pharmacovigilance unit of central portugal and its contribution for drug safety knowledge XLII Reunião Anual da Sociedade Portuguesa de Farmacologia
Sociedade Portuguesa de Farmacologia (Lisboa, Portugal)
2012 Evaluation of the severity of adverse drug reactions reported from hospitals and ambulatory care settings: an update XLII Reunião Anual da Sociedade Portuguesa de Farmacologia
Sociedade Portuguesa de Farmacologia (Lisboa, Portugal)
2011 Increased severity of adverse drug reactions reported from hospitals: an exploratory study XLI Reunião Anual da Sociedade Portuguesa de Farmacologia
Sociedade Portuguesa de Farmacologia (Coimbra, Portugal)
2011 Safety of medicines: review data used in meta-analysis VI Annual CICS Symposium
Centro de Investigação em Ciências da Saúde (Covilhã, Portugal)

Supervision

Thesis Title
Role 		Degree Subject (Type)
Institution / Organization
2022/09/01 - 2023/10/17 Characterization of the Comparisons Established for Pharmacotherapeutic Evaluation in Health Technologies Assessment
Supervisor
 Mestrado em Farmacologia Aplicada (Master)
Universidade de Coimbra Faculdade de Farmácia, Portugal
2023/01/02 - 2023/10/16 Caracterização dos processos de avaliação terapêutica de medicamentos utilizados no tratamento de Doenças Inflamatórias do Intestino
Supervisor
 Mestrado Integrado em Ciências Farmacêuticas (Master)
Universidade de Coimbra Faculdade de Farmácia, Portugal
2023/01/02 - 2023/07/25 Análise de Processos de Financiamento de Medicamentos utilizados no Tratamento da Insuficiência Cardíaca
Supervisor
 Mestrado Integrado em Ciências Farmacêuticas (Master)
Universidade de Coimbra Faculdade de Farmácia, Portugal
2022/01/02 - 2022/09/27 A Efetividade do Alemtuzumab no Tratamento da Esclerose Múltipla
Supervisor
 Mestrado Integrado em Ciências Farmacêuticas (Master)
Universidade de Coimbra Faculdade de Farmácia, Portugal
2022/01/02 - 2022/09/15 Vacinas contra a COVID-19: efeito secundário hipertensão arterial
Supervisor
 Mestrado Integrado em Ciências Farmacêuticas (Master)
Universidade de Coimbra Faculdade de Farmácia, Portugal
2022/01/02 - 2022/07/19 Inibidores SGLT2 e Cetoacidose Diabética"
Supervisor
 Mestrado Integrado em Ciências Farmacêuticas (Master)
Universidade de Coimbra Faculdade de Farmácia, Portugal
2021/01/02 - 2021/10/14 Financiamento Público de Medicamentos Órfãos em Portugal
Supervisor
 Mestrado Integrado em Ciências Farmacêuticas (Master)
2021/01/02 - 2021/07/29 Financiamento de Medicamentos Biológicos: Alternativas para Doenças Autoimunes
Supervisor
 Mestrado Integrado em Ciências Farmacêuticas (Master)
Universidade de Coimbra Faculdade de Farmácia, Portugal
2021/01/02 - 2021/07/29 A alteração do consumo de antidepressivos e ansiolíticos com a pandemia COVID-19
Supervisor
 Mestrado Integrado em Ciências Farmacêuticas (Master)
Universidade de Coimbra Faculdade de Farmácia, Portugal
2017/06/13 - 2021 Economic evaluation of ophthalmic medicines: does the results estimated based on pre-marketing evidence correlates with clinical practice?
Supervisor
Universidade de Coimbra Faculdade de Farmácia, Portugal
2020/01/02 - 2020/10/07 Avaliação do perfil de segurança do baricitinib em doentes com artrite reumatoide
Supervisor
 Mestrado Integrado em Ciências Farmacêuticas (Master)
2020/01/02 - 2020/10/06 Meta-análise: Avaliação do risco da utilização do Upadacitinib no tratamento da Artrite Reumatoide
Supervisor
 Mestrado Integrado em Ciências Farmacêuticas (Master)
2020/01/02 - 2020/07/28 A enxaqueca enquanto reação adversa ao medicamento
Supervisor
 Mestrado Integrado em Ciências Farmacêuticas (Master)
Universidade de Coimbra Faculdade de Farmácia, Portugal
2018/09/01 - 2020/02/27 Polypharmacy as an Independent Risk Factor For Serious Adverse Drug Reactions - A Systematic Review
Supervisor
Universidade de Coimbra Faculdade de Farmácia, Portugal
2019/01/02 - 2019/09/18 Avaliação de Tecnologias de Saúde: Avaliação Farmacoterapêutica de Medicamentos
Supervisor
 Mestrado Integrado em Ciências Farmacêuticas (Master)
Universidade de Coimbra Faculdade de Farmácia, Portugal
2019/01/02 - 2019/07/24 A Relação entre o Processo de Autorização de Introdução no Mercado e a Obtenção de Financiamento do Medicamento
Supervisor
 Mestrado Integrado em Ciências Farmacêuticas (Master)
Universidade de Coimbra Faculdade de Farmácia, Portugal
2019/01/02 - 2019/07/16 O estabelecimento de comparações na avaliação farmacoterapêutica de medicamentos em Portugal
Supervisor
 Mestrado Integrado em Ciências Farmacêuticas (Master)
2018/01/02 - 2018/09/18 Esquizofrenia: Patologia e Estratégias Terapêuticas
Supervisor
 Mestrado Integrado em Ciências Farmacêuticas (Master)
Universidade de Coimbra Faculdade de Farmácia, Portugal
2018/01/02 - 2018/07/26 Iatrogenia Gastrointestinal dos AINEs
Supervisor
 Mestrado Integrado em Ciências Farmacêuticas (Master)
Universidade de Coimbra Faculdade de Farmácia, Portugal
2018/01/02 - 2018/07/26 Iatrogenia de quinolonas: uma análise de notificações espontâneas
Supervisor
 Mestrado Integrado em Ciências Farmacêuticas (Master)
Universidade de Coimbra Faculdade de Farmácia, Portugal
2017/01/02 - 2017/07/27 Qualidade de Vida Associada aos Medicamentos Antidiabéticos Indicados na Diabetes Mellitus Tipo 2
Supervisor
 Mestrado Integrado em Ciências Farmacêuticas (Master)
Universidade de Coimbra Faculdade de Farmácia, Portugal
2017/01/02 - 2017/07/27 Custos do Tratamento de Hipoglicémias Associadas à Toma de Antidiabéticos Orais
Supervisor
 Mestrado Integrado em Ciências Farmacêuticas (Master)
2017/01/02 - 2017/07/14 Avaliação de tecnologias em saúde – a figura da reavaliação na Europa
Supervisor
 Mestrado Integrado em Ciências Farmacêuticas (Master)
2016/01/02 - 2016/09/30 Estudo comparativo entre as RAM reportadas à UFC e os sinais de segurança reportados ao PRAC entre 2013 e 2015
Supervisor
 Mestrado Integrado em Ciências Farmacêuticas (Master)
Universidade de Coimbra Faculdade de Farmácia, Portugal
2016/01/02 - 2016/09/30 Análise dos relatórios de avaliação dos medicamentos retirados do mercado por razões de segurança
Supervisor
 Mestrado Integrado em Ciências Farmacêuticas (Master)
2016/01/02 - 2016/09/30 Processo de retirada de substâncias do mercado por razões de segurança entre os anos de 2005 a 2015
Supervisor
 Mestrado Integrado em Ciências Farmacêuticas (Master)
Universidade de Coimbra Faculdade de Farmácia, Portugal
2015/01/02 - 2015/09/18 Key Performance Indicators em Unidades Regionais de Farmacovigilância
Supervisor
 Mestrado Integrado em Ciências Farmacêuticas (Master)
Universidade de Coimbra Faculdade de Farmácia, Portugal

Event participation

Activity description
Type of event 		Event name
Institution / Organization
2014 - 2014 Sistema Nacional de Farmacovigilância - Noções gerais e Atividade da Unidade de Farmacovigilância do Centro
Workshop
 Ação de Divulgação - Sistema Nacional de Farmacovigilância - Noções gerais e Atividade da Unidade de Farmacovigilância do Centro
Unidade de Farmacovigilância do Centro - AIBILI, Portugal
2012 - 2012 Avaliação de Tecnologias em Saúde
Symposium
 XIII Jornadas Ciências Farmacêuticas do Núcleo de Ciências Farmacêuticas da Associação de Estudantes do ISCS-Norte
Núcleo de Ciências Farmacêuticas da Associação de Estudantes do ISCS-Norte, Portugal
2012 - 2012 Estudos epidemiológicos e nível de evidência
Symposium
 XIII Jornadas de Ciências Farmacêuticas do Núcleo de Ciências Farmacêuticas da Associação de Estudantes do ISCS-Norte
Núcleo de Ciências Farmacêuticas da Associação de Estudantes do ISCS-Norte, Portugal
2012 - 2012 Avaliação do valor terapêutico do Medicamento A na prevenção do tromboembolismo venoso
Symposium
 XIII Jornadas de Ciências Farmacêuticas do Núcleo de Ciências Farmacêuticas da Associação de Estudantes do ISCS-Norte
Núcleo de Ciências Farmacêuticas da Associação de Estudantes do ISCS-Norte, Portugal
2012 - 2012 Sistema Nacional de Farmacovigilância - Noções Gerais e Actividades da UFC
Workshop
 Ação de Divulgação da UFC - Sistema Nacional de Farmacovigilância - Noções Gerais e Actividades da UFC
Unidade de Farmacovigilância do Centro - AIBILI, Portugal
2012 - 2012 Sistema Nacional de Farmacovigilância - Noções Gerais e o Contributo dos Enfermeiros para a Farmacovigilância
Workshop
 Ação de divulgação da UFC - Sistema Nacional de Farmacovigilância - Noções Gerais e o Contributo dos Enfermeiros para a Farmacovigilância
Unidade de Farmacovigilância do Centro - AIBILI, Portugal
2012 - 2012 Sistema Nacional de Farmacovigilância - Noções Gerais e Actividades da UFC
Workshop
 Ação de Divulgação da UFC - Sistema Nacional de Farmacovigilância - Noções Gerais e Actividades da UFC
Unidade de Farmacovigilância do Centro - AIBILI, Portugal

Jury of academic degree

Topic
Role 		Candidate name (Type of degree)
Institution / Organization
2023/10/31 Desabastecimento no Mercado Farmacêutico: Causas e Consequências
(Thesis) Main arguer
 David dos Santos da Fonseca Vieira Gomes (Master)
Universidade de Coimbra Faculdade de Farmácia, Portugal
2023/10/20 Caracterização dos processos de avaliação terapêutica de medicamentos utilizados no tratamento de cancros hematológicos
(Thesis) Main arguer
 Marta Carvalho Amaro (Master)
Universidade de Coimbra Faculdade de Farmácia, Portugal
2023/10/16 Impactos no custo dos medicamentos decorrentes de cenários de incerteza
(Thesis) Main arguer
 Guilherme Coutinho Rato Baleiras (Master)
Universidade de Coimbra Faculdade de Farmácia, Portugal
2023/10/11 Caracterização dos Processos de Avaliação de Tecnologias de Saúde de Medicamentos Utilizados no Tratamento do Cancro da Mama
Supervisor
 Ricardo Costa Silva (Master)
Universidade de Coimbra Faculdade de Farmácia, Portugal
2023/10/02 Caracterização dos processos de avaliação terapêutica de medicamentos utilizados no tratamento da Artrite Reumatoide
(Thesis) Main arguer
 Maria Jorge Balau e Flores (Master)
Universidade de Coimbra Faculdade de Farmácia, Portugal
2023/09/20 Caracterização dos processos de avaliação terapêutica de medicamentos utilizados no tratamento de fibrose quística
(Thesis) Main arguer
 Mariana Raínho Simões (Master)
Universidade de Coimbra Faculdade de Farmácia, Portugal
2023/07/28 A forma como os doentes renovam as suas prescrições médicas: um estudo preliminar
(Thesis) Main arguer
 Marta Portulez Gigante (Master)
Universidade de Coimbra Faculdade de Farmácia, Portugal
2023/07/26 Análise do desperdício de medicamentos em estruturas residenciais para idosos
(Thesis) Main arguer
 Joana Pereira Louro (Master)
Universidade de Coimbra Faculdade de Farmácia, Portugal
2023/07/20 Caracterização dos processos de avaliação terapêutica de medicamentos utilizados no tratamento do cancro da pele: carcinoma basocelular, carcinoma espinocelular e melanoma
(Thesis) Main arguer
 Tânia Isabel Pessoa Branco (Master)
Universidade de Coimbra Faculdade de Farmácia, Portugal
2023/02/27 Identification of Unknown and Serious Adverse Drug Reactions for COVID-19 Vaccines in Spontaneous Reports Received by the Pharmacovigilance Unit of Coimbra
(Thesis) Main arguer
 Inês Filipa Guerra Tavares (Master)
Universidade de Coimbra Faculdade de Farmácia, Portugal
2022/10/07 A era digital na Farmácia Comunitária
Supervisor
 Ana Beatriz Camilo Alves Serpa (Master)
Universidade de Coimbra Faculdade de Farmácia, Portugal
2022/10/04 Evolução do Sistema de Farmacovigilância Português
(Thesis) Main arguer
 Verónica da Silva Resende (Master)
Universidade de Coimbra Faculdade de Farmácia, Portugal
2022/07/14 Evolução da repartição de encargos com o medicamento entre o mercado ambulatório e o mercado hospitalar nos últimos 10 anos
Supervisor
 Filipa Alexandra Machado Ferreira (Master)
Universidade de Coimbra Faculdade de Farmácia, Portugal
2021/12/03 Avaliação das notificações espontâneas submetidas por farmacêuticos quanto à gravidade, causalidade e conhecimento prévio
(Thesis) Main arguer
 Elsa Filipa Pereira Martins (Master)
Universidade de Coimbra Faculdade de Farmácia, Portugal
2021/11/17 Orientações metodológicas para estudos de avaliação económica de tecnologias de saúde 1999/2019
(Thesis) Main arguer
 Maria Carolina Rojais Cordeiro (Master)
Universidade de Coimbra Faculdade de Farmácia, Portugal
2021/11/10 Reações Adversas a Medicamentos: distribuição por frequência, gravidade e conhecimento prévio cruzado com intervalos etários e sexo
(Thesis) Main arguer
 Sofia Isabel Fernandes Gouveia (Master)
Universidade de Coimbra Faculdade de Farmácia, Portugal
2021/11/05 Análise de reações adversas medicamentosas a antineoplásicos
(Thesis) Main arguer
 Bianca Sara Varandas Sá (Master)
Universidade de Coimbra Faculdade de Farmácia, Portugal
2021/07/27 O uso da inteligência artificial no processo de investigação e desenvolvimento em oncologia
(Thesis) Main arguer
 Eduarda Coutinho Ribeiro (Master)
Universidade de Coimbra Faculdade de Farmácia, Portugal
2021/02/01 Patterns of polypharmacy and potential overtreatment in elderly people with type 2 diabetes mellitus using real-world data
(Thesis) Main arguer
 Labib Abdulrasool Abdulrasak Al-Musawe (PhD)
Universidade de Lisboa Faculdade de Farmácia, Portugal
2020/11/23 O uso concomitante de anti-inflamatórios não esteroides e anti-hipertensores
Supervisor
 Pedro Miguel Santos Rodrigues (Master)
Universidade de Coimbra Faculdade de Farmácia, Portugal
2020/10/22 Estudo da Evolução do Consumo de Antibióticos no Ambulatório do SNS em Portugal
(Thesis) Main arguer
 Rita Ribeiro Mega (Master)
Universidade de Coimbra Faculdade de Farmácia, Portugal
2020/06/01 Systematic review: methodological aspects of its role in drug safety assessment
(Thesis) Arguer
 Ana Sofia Martins Penedones (PhD)
Universidade de Coimbra Faculdade de Farmácia, Portugal
2019/07/16 Literacia dos utentes em cuidados farmacêuticos na Dislipidémia, DPOC, Hipertensão e Diabetes
(Thesis) Main arguer
 André Parada Lopes (Master)
Universidade de Coimbra Faculdade de Farmácia, Portugal
2018/09/27 Innovation in Health: first contribution to the development of a New Practice Model for Clinical Pharmacists in Primary Healthcare
(Thesis) Main arguer
 Ana Filipa Oliveira Costa Dias Lourenço (Master)
Universidade de Coimbra Faculdade de Economia, Portugal
2018/09/20 Avaliação do contributo para a Farmacovigilância das Notificações de Reações Adversas a Medicamentos com origem em Utentes.
(Thesis) Main arguer
 Regina Maria Pimenta de Moura (Master)
Universidade de Coimbra Faculdade de Farmácia, Portugal
2018/09/12 Revisão de Segurança dos Medicamentos Biológicos aprovados para o tratamento da Doença de Crohn em Portugal
(Thesis) Main arguer
 Ana Irene Comprido Nascimento (Master)
Universidade de Coimbra Faculdade de Farmácia, Portugal
2018/07/06 Budget Impact Analysis - a review
(Thesis) Main arguer
 Gonçalo Ferreira Pinto Mendes (Master)
Universidade de Coimbra Faculdade de Farmácia, Portugal
2018 Influência da idade e da polimedicação na frequência e gravidade das reacções adversas a medicamentos
(Thesis) Main arguer
 Ana Sofia São Simão Horta (Master)
Universidade de Coimbra Faculdade de Farmácia, Portugal
2017/12/13 Benefit-risk assessment of medicines: a contribution for evidence-based decisions using the number needed to treat to benefit or to harm
(Thesis) Arguer
 Diogo Manuel de Jesus Mendes (PhD)
Universidade de Coimbra Faculdade de Farmácia, Portugal
2017/10/06 Caracterização de Reações de Hipersensibilidade a Medicamentos
(Thesis) Main arguer
 Ana Rita de Jesus Oliveira (Master)
2017/09/21 PSUR: Identificação, Organização e Avaliação Crítica das Fontes de Informação
(Thesis) Main arguer
 Duarte Fernandes de Jesus (Master)
Universidade de Coimbra Faculdade de Farmácia, Portugal
2016/07/26 Os critérios de avaliação dos sistemas de farmacovigilância da Bélgica, Canadá, Holanda e Portugal
(Thesis) Main arguer
 Engrácia Maria Santos Nobre (Master)
2015/09/29 SINATS-um sistema de avaliação de tecnologias de saúde para Portugal
(Thesis) Main arguer
 José Pedro Nogueira Carvalho (Master)
Universidade de Coimbra Faculdade de Farmácia, Portugal
2015/09/19 Revisão do tratamento atual da hipertensão arterial com foco nas diferenças entre a norma americana de 2000 e 2014
(Thesis) Main arguer
 Alexandre Canavarro Bahcevandziev (Master)
Universidade de Coimbra Faculdade de Farmácia, Portugal
2015/09/19 Aspirina versus parecetemol no tratamento de cefaleias primárias
(Thesis) Main arguer
 Luís Guilherme Loureiro Albuquerque Antunes (Master)
Universidade de Coimbra Faculdade de Farmácia, Portugal
2015/07/24 Custo das reacções adversas a medicamentos: revisão da literatura
(Thesis) Main arguer
 Jose Pedro Lopes Castelo Branco Catré (Master)
Universidade de Coimbra Faculdade de Farmácia, Portugal

Association member

Society Organization name Role
2023 - Current ISPOR - The Professional Society for Health Economics and Outcomes Research
2018 - Current Sociedade Portuguesa de Farmacologia Associate member
2012/10 - Current Sociedade Portuguesa de Farmácia Clínica e Farmacoterapia
2009/09 - Current Ordem dos Farmacêuticos

Conference scientific committee

Conference name Conference host
2023/06 - 2023/11 International Society For Pharmacoeconomics and Outcomes Research (ISPOR) 2023 European Congress Copenhagen, Denmark
2020/02 - 2020/08 36th International Conference on Pharmacoepidemiology and Therapeutic Risk Management Virtual
2019/02 - 2019/08 35th International Conference on Pharmacoepidemiology and Therapeutic Risk Management Philadelphia, PA, USA
2018/02 - 2018/08 34th International Conference on Pharmacoepidemiology and Therapeutic Risk Management Prague, Czech Republic
2017/02 - 2017/08 33rd International Conference on Pharmacoepidemiology and Therapeutic Risk Management Montreal, Canada
2016/02 - 2016/08 32nd International Conference on Pharmacoepidemiology (ICPE) and Therapeutic Risk Management Dublin, Ireland
2015/02 - 2015/08 31st International Conference on Pharmacoepidemiology and Therapeutic Risk Management Boston, MA, USA
2013/02 - 2013/08 29th International Conference on Pharmacoepidemiology and Therapeutic Risk Management Montreal, Canada

Course / Discipline taught

Academic session Degree Subject (Type) Institution / Organization
2022/07 - 2022/07 Segurança de medicamentos, Farmacovigilância e Farmacoepidemiologia Pós-graduação em medicina farmacêutica
2021/11 - 2022 Evidence Synthesis in Drug Safety Medicines and Medical Devices (Pós-Graduação)
2020/11 - 2021 Medicines under additional surveillance (Safety and risk management in the real-world clinical practice) Medicines and Medical Devices (Pós-Graduação)
2013 - 2013 Curso de Pós-Graduação em Farmacoterapia - Princípios gerais da avaliação económica de medicamentos Aperfeiçoamento (Curso médio) Associação Nacional das Farmácias, Portugal
2013 - 2013 Curso de Pós-Graduação em Farmacoterapia - Organização da informação de suporte à tomada de decisão terapêutica Aperfeiçoamento (Curso médio) Associação Nacional das Farmácias, Portugal
2013 - 2013 Curso de Pós-Graduação em Farmacoterapia - Workshop II Aperfeiçoamento (Curso médio) Associação Nacional das Farmácias, Portugal
2013 - 2013 Curso de Pós-Graduação em Farmacoterapia - Workshop III Aperfeiçoamento (Curso médio) Associação Nacional das Farmácias, Portugal
2013 - 2013 Curso de Pós-Graduação em Farmacoterapia - Módulo VI - Farmacoterapia Avançada Aperfeiçoamento (Curso médio) Associação Nacional das Farmácias, Portugal

Interview (newspaper / magazine)

Activity description Newspaper / Forum
2022/03/30 Investigando na UC "Avaliação de Tecnologias em Saúde" Diário "As Beiras"

Journal scientific committee

Journal title (ISSN) Publisher
2021/04/07 - Current Journal of Clinical Medicines (2077-0383) MDPI
2021/03/30 - Current Frontiers in Pharmacology (1663-9812) Frontiers
Distinctions

Award

2016 IV Reunião Cientifica Anual da Sociedade Portuguesa de Farmácia Clínica ou Farmacoterapia - 1º prémio Comissão Científica
Sociedade Portuguesa de Farmácia Clínica ou Farmacoterapia, Portugal
2015 Prémio de Investigação Científica Professora Doutora Maria Odette Santos­-Ferreira
Ordem dos Farmaceuticos, Portugal
2015 ACCP Virtual Poster Symposium Best Paper Awards - 3rd prize
American College of Clinical Pharmacy, United States